Abstract
Background: Household air pollution (HAP) from cooking with solid fuels has been associated with adverse respiratory effects, but most studies use surveys of fuel use to define HAP exposure, rather than on actual air pollution exposure measurements. Objective: To examine associations between household and personal fine particulate matter (PM2.5) and black carbon (BC) measures and respiratory symptoms. Methods: As part of the Prospective Urban and Rural Epidemiology Air Pollution study, we analyzed 48-h household and personal PM2.5 and BC measurements for 870 individuals using different cooking fuels from 62 communities in 8 countries (Bangladesh, Chile, China, Colombia, India, Pakistan, Tanzania, and Zimbabwe). Self-reported respiratory symptoms were collected after monitoring. Associations between PM2.5 and BC exposures and respiratory symptoms were examined using logistic regression models, controlling for individual, household, and community covariates. Results: The median (interquartile range) of household and personal PM2.5 was 73.5 (119.1) and 65.3 (91.5) μg/m3, and for household and personal BC was 3.4 (8.3) and 2.5 (4.9) x10−5 m−1, respectively. We observed associations between household PM2.5 and wheeze (OR: 1.25; 95%CI: 1.07, 1.46), cough (OR: 1.22; 95%CI: 1.06, 1.39), and sputum (OR: 1.26; 95%CI: 1.10, 1.44), as well as exposure to household BC and wheeze (OR: 1.20; 95%CI: 1.03, 1.39) and sputum (OR: 1.20; 95%CI: 1.05, 1.36), per IQR increase. We observed associations between personal PM2.5 and wheeze (OR: 1.23; 95%CI: 1.00, 1.50) and sputum (OR: 1.19; 95%CI: 1.00, 1.41). For household PM2.5 and BC, associations were generally stronger for females compared to males. Models using an indicator variable of solid versus clean fuels resulted in larger OR estimates with less precision. Conclusions: We used measurements of household and personal air pollution for individuals using different cooking fuels and documented strong associations with respiratory symptoms.
Original language | English |
---|---|
Article number | 113430 |
Journal | Environmental Research |
Volume | 212 |
DOIs | |
Publication status | Published - Sept 2022 |
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Personal and household PM2.5 and black carbon exposure measures and respiratory symptoms in 8 low- and middle-income countries'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Environmental Research, Vol. 212, 113430, 09.2022.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Personal and household PM2.5 and black carbon exposure measures and respiratory symptoms in 8 low- and middle-income countries
AU - PURE-AIR study investigators
AU - Wang, Ying
AU - Shupler, Matthew
AU - Birch, Aaron
AU - Chu, Yen Li
AU - Jeronimo, Matthew
AU - Rangarajan, Sumathy
AU - Mustaha, Maha
AU - Heenan, Laura
AU - Seron, Pamela
AU - Saavedra, Nicolas
AU - Oliveros, Maria Jose
AU - Lopez-Jaramillo, Patricio
AU - Camacho, Paul A.
AU - Otero, Johnna
AU - Perez-Mayorga, Maritza
AU - Yeates, Karen
AU - West, Nicola
AU - Ncube, Tatenda
AU - Ncube, Brian
AU - Chifamba, Jephat
AU - Yusuf, Rita
AU - Khan, Afreen
AU - Liu, Zhiguang
AU - Cheng, Xiaoru
AU - Wei, Li
AU - Tse, L. A.
AU - Mohan, Deepa
AU - Kumar, Parthiban
AU - Gupta, Rajeev
AU - Mohan, Indu
AU - Jayachitra, K. G.
AU - Mony, Prem K.
AU - Rammohan, Kamala
AU - Nair, Sanjeev
AU - Lakshmi, P. V.M.
AU - Sagar, Vivek
AU - Khawaja, Rehman
AU - Iqbal, Romaina
AU - Kazmi, Khawar
AU - Yusuf, Salim
AU - Brauer, Michael
AU - Hystad, Perry
N1 - Funding Information: The PURE-AIR study is funded by the Canadian Institutes of Health Research (grant #136893) and by the Office of The Director, National Institutes of Health (NIH; Award Number DP5OD019850). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Canadian Institutes of Health Research or the NIH. Dr S Yusuf is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies [with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline], and additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries. These include: Argentina: Fundacion ECLA (Estudios Clínicos Latino America); Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: This study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (U.S.), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera [DI13-PE11]; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007], and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0), Wroclaw Medical University; Saudi Arabia: Saudi Heart Association. Saudi Gastroenterology Association. Dr. Mohammad Alfagih Hospital. The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group 35 number: RG -1436-013); South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: Grants from the Swedish state under the Agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation; the Swedish Research Council; the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis; United Arab Emirates: Sheikh Hamdan Bin Role of Sponsor: The external Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai. Funding Information: The PURE-AIR study is funded by the Canadian Institutes of Health Research (grant #136893 ) and by the Office of The Director, National Institutes of Health (NIH; Award Number DP5OD019850 ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Canadian Institutes of Health Research or the NIH. Dr S Yusuf is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute , Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research , Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research , through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies [with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier , and GlaxoSmithKline ], and additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries. These include: Argentina: Fundacion ECLA (Estudios Clínicos Latino America) ; Bangladesh : Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: This study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (U.S.) , Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network ; Chile: Universidad de La Frontera [ DI13-PE11 ]; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development ; Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228 ); India: Indian Council of Medical Research ; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007 ], and 07-05-IFN-BPH 010 ), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011] ), Universiti Teknologi MARA , Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre , Canada; Philippines: Philippine Council for Health Research and Development ; Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0 ), Wroclaw Medical University ; Saudi Arabia: Saudi Heart Association . Saudi Gastroenterology Association. Dr. Mohammad Alfagih Hospital. The Deanship of Scientific Research at King Saud University , Riyadh, Saudi Arabia (Research group 35 number: RG -1436-013 ); South Africa: The North-West University , SA and Netherlands Programme for Alternative Development , National Research Foundation , Medical Research Council of South Africa , The South Africa Sugar Association , Faculty of Community and Health Sciences; Sweden: Grants from the Swedish state under the Agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation ; the Swedish Research Council ; the Swedish Council for Health, Working Life and Welfare , King Gustaf V:s and Queen Victoria Freemason's Foundation , AFA Insurance ; Turkey: Metabolic Syndrome Society , AstraZeneca , Sanofi Aventis ; United Arab Emirates: Sheikh Hamdan Bin Role of Sponsor : The external Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai. Publisher Copyright: © 2022
PY - 2022/9
Y1 - 2022/9
N2 - Background: Household air pollution (HAP) from cooking with solid fuels has been associated with adverse respiratory effects, but most studies use surveys of fuel use to define HAP exposure, rather than on actual air pollution exposure measurements. Objective: To examine associations between household and personal fine particulate matter (PM2.5) and black carbon (BC) measures and respiratory symptoms. Methods: As part of the Prospective Urban and Rural Epidemiology Air Pollution study, we analyzed 48-h household and personal PM2.5 and BC measurements for 870 individuals using different cooking fuels from 62 communities in 8 countries (Bangladesh, Chile, China, Colombia, India, Pakistan, Tanzania, and Zimbabwe). Self-reported respiratory symptoms were collected after monitoring. Associations between PM2.5 and BC exposures and respiratory symptoms were examined using logistic regression models, controlling for individual, household, and community covariates. Results: The median (interquartile range) of household and personal PM2.5 was 73.5 (119.1) and 65.3 (91.5) μg/m3, and for household and personal BC was 3.4 (8.3) and 2.5 (4.9) x10−5 m−1, respectively. We observed associations between household PM2.5 and wheeze (OR: 1.25; 95%CI: 1.07, 1.46), cough (OR: 1.22; 95%CI: 1.06, 1.39), and sputum (OR: 1.26; 95%CI: 1.10, 1.44), as well as exposure to household BC and wheeze (OR: 1.20; 95%CI: 1.03, 1.39) and sputum (OR: 1.20; 95%CI: 1.05, 1.36), per IQR increase. We observed associations between personal PM2.5 and wheeze (OR: 1.23; 95%CI: 1.00, 1.50) and sputum (OR: 1.19; 95%CI: 1.00, 1.41). For household PM2.5 and BC, associations were generally stronger for females compared to males. Models using an indicator variable of solid versus clean fuels resulted in larger OR estimates with less precision. Conclusions: We used measurements of household and personal air pollution for individuals using different cooking fuels and documented strong associations with respiratory symptoms.
AB - Background: Household air pollution (HAP) from cooking with solid fuels has been associated with adverse respiratory effects, but most studies use surveys of fuel use to define HAP exposure, rather than on actual air pollution exposure measurements. Objective: To examine associations between household and personal fine particulate matter (PM2.5) and black carbon (BC) measures and respiratory symptoms. Methods: As part of the Prospective Urban and Rural Epidemiology Air Pollution study, we analyzed 48-h household and personal PM2.5 and BC measurements for 870 individuals using different cooking fuels from 62 communities in 8 countries (Bangladesh, Chile, China, Colombia, India, Pakistan, Tanzania, and Zimbabwe). Self-reported respiratory symptoms were collected after monitoring. Associations between PM2.5 and BC exposures and respiratory symptoms were examined using logistic regression models, controlling for individual, household, and community covariates. Results: The median (interquartile range) of household and personal PM2.5 was 73.5 (119.1) and 65.3 (91.5) μg/m3, and for household and personal BC was 3.4 (8.3) and 2.5 (4.9) x10−5 m−1, respectively. We observed associations between household PM2.5 and wheeze (OR: 1.25; 95%CI: 1.07, 1.46), cough (OR: 1.22; 95%CI: 1.06, 1.39), and sputum (OR: 1.26; 95%CI: 1.10, 1.44), as well as exposure to household BC and wheeze (OR: 1.20; 95%CI: 1.03, 1.39) and sputum (OR: 1.20; 95%CI: 1.05, 1.36), per IQR increase. We observed associations between personal PM2.5 and wheeze (OR: 1.23; 95%CI: 1.00, 1.50) and sputum (OR: 1.19; 95%CI: 1.00, 1.41). For household PM2.5 and BC, associations were generally stronger for females compared to males. Models using an indicator variable of solid versus clean fuels resulted in larger OR estimates with less precision. Conclusions: We used measurements of household and personal air pollution for individuals using different cooking fuels and documented strong associations with respiratory symptoms.
UR - http://www.scopus.com/inward/record.url?scp=85129707807&partnerID=8YFLogxK
U2 - 10.1016/j.envres.2022.113430
DO - 10.1016/j.envres.2022.113430
M3 - Article
C2 - 35526584
AN - SCOPUS:85129707807
SN - 0013-9351
VL - 212
JO - Environmental Research
JF - Environmental Research
M1 - 113430
ER -